BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38387831)

  • 1. Pathologic Assessment and Staging of Multiple Non-Small Cell Lung Carcinomas: A Paradigm Shift with the Emerging Role of Molecular Methods.
    Chang JC; Rekhtman N
    Mod Pathol; 2024 May; 37(5):100453. PubMed ID: 38387831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach.
    Chang JC; Alex D; Bott M; Tan KS; Seshan V; Golden A; Sauter JL; Buonocore DJ; Vanderbilt CM; Gupta S; Desmeules P; Bodd FM; Riely GJ; Rusch VW; Jones DR; Arcila ME; Travis WD; Ladanyi M; Rekhtman N
    Clin Cancer Res; 2019 Dec; 25(23):7113-7125. PubMed ID: 31471310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are there imaging characteristics that can distinguish separate primary lung carcinomas from intrapulmonary metastases using next-generation sequencing as a gold standard?
    Araujo-Filho JAB; Chang J; Mayoral M; Plodkowski AJ; Perez-Johnston R; Lobaugh S; Zheng J; Rusch VW; Rekhtman N; Ginsberg MS
    Lung Cancer; 2021 Mar; 153():158-164. PubMed ID: 33529990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer.
    Zheng R; Shen Q; Mardekian S; Solomides C; Wang ZX; Evans NR
    J Thorac Cardiovasc Surg; 2020 Aug; 160(2):e71-e79. PubMed ID: 32007245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases.
    Girard N; Deshpande C; Lau C; Finley D; Rusch V; Pao W; Travis WD
    Am J Surg Pathol; 2009 Dec; 33(12):1752-64. PubMed ID: 19773638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Profiling With Large-Scale Next-Generation Sequencing Panels Distinguishes Separate Primary Lung Adenocarcinomas From Intrapulmonary Metastases.
    Yang CY; Yeh YC; Wang LC; Lin YY; Lin SY; Wang SY; Chu PY; Liu ZY; Su YC; Ho HL; Chou TY
    Mod Pathol; 2023 Mar; 36(3):100047. PubMed ID: 36788096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic Assessment.
    Dacic S; Cao X; Bota-Rabassedas N; Sanchez-Espiridion B; Berezowska S; Han Y; Chung JH; Beasley MB; Dongmei L; Hwang D; Mino-Kenudson M; Minami Y; Papotti M; Rekhtman N; Roden AC; Thunnissen E; Tsao MS; Yatabe Y; Yoshida A; Wang L; Hartman DJ; Jerome JA; Kadara H; Chou TY; Wistuba II;
    J Thorac Oncol; 2024 Feb; 19(2):273-284. PubMed ID: 37717856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological and molecular approach to synchronous non-small cell lung carcinomas: impact on staging.
    Schneider F; Derrick V; Davison JM; Strollo D; Incharoen P; Dacic S
    Mod Pathol; 2016 Jul; 29(7):735-42. PubMed ID: 27080983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinical Use of Genomic Profiling to Distinguish Intrapulmonary Metastases From Synchronous Primaries in Non-Small-Cell Lung Cancer: A Mini-Review.
    Klempner SJ; Ou SH; Costa DB; VanderLaan PA; Sanford EM; Schrock A; Gay L; Ali SM; Miller VA
    Clin Lung Cancer; 2015 Sep; 16(5):334-339.e1. PubMed ID: 25911330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy.
    Warth A; Macher-Goeppinger S; Muley T; Thomas M; Hoffmann H; Schnabel PA; Penzel R; Schirmacher P; Aulmann S
    Eur Respir J; 2012 Jun; 39(6):1437-42. PubMed ID: 22075483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression.
    Awad MM; Oxnard GR; Jackman DM; Savukoski DO; Hall D; Shivdasani P; Heng JC; Dahlberg SE; Jänne PA; Verma S; Christensen J; Hammerman PS; Sholl LM
    J Clin Oncol; 2016 Mar; 34(7):721-30. PubMed ID: 26729443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.
    Schrock AB; Li SD; Frampton GM; Suh J; Braun E; Mehra R; Buck SC; Bufill JA; Peled N; Karim NA; Hsieh KC; Doria M; Knost J; Chen R; Ou SI; Ross JS; Stephens PJ; Fishkin P; Miller VA; Ali SM; Halmos B; Liu JJ
    J Thorac Oncol; 2017 Jun; 12(6):932-942. PubMed ID: 28315738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromogenic immunohistochemical quadruplex provides accurate diagnostic differentiation of non-small cell lung cancer.
    Roberts EA; Morrison LE; Behman LJ; Draganova-Tacheva R; O'Neill R; Solomides CC
    Ann Diagn Pathol; 2020 Apr; 45():151454. PubMed ID: 31923744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of N-acetylglucosaminyltransferase v is associated with prognosis and histology in non-small cell lung cancers.
    Dosaka-Akita H; Miyoshi E; Suzuki O; Itoh T; Katoh H; Taniguchi N
    Clin Cancer Res; 2004 Mar; 10(5):1773-9. PubMed ID: 15014031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of independent primary tumors and intrapulmonary metastases using DNA rearrangements in non-small-cell lung cancer.
    Murphy SJ; Aubry MC; Harris FR; Halling GC; Johnson SH; Terra S; Drucker TM; Asiedu MK; Kipp BR; Yi ES; Peikert T; Yang P; Vasmatzis G; Wigle DA
    J Clin Oncol; 2014 Dec; 32(36):4050-8. PubMed ID: 25385739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer.
    Miyoshi T; Kondo K; Hino N; Uyama T; Monden Y
    Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers.
    Lee SY; Kim MJ; Jin G; Yoo SS; Park JY; Choi JE; Jeon HS; Cho S; Lee EB; Cha SI; Park TI; Kim CH; Jung TH; Park JY
    J Thorac Oncol; 2010 Nov; 5(11):1734-40. PubMed ID: 20881644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologists' staging of multiple foci of lung cancer: poor concordance in absence of dramatic histologic or molecular differences.
    Homer RJ
    Am J Clin Pathol; 2015 May; 143(5):701-6. PubMed ID: 25873504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
    Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
    Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.